ExplorerVirologyOpen Science
Research PaperResearchia:202606.28010

Novel Compounds as SARS-CoV-2 Main Protease Inhibitors for Treating Viral Infections, in particular, Coronavirus Infections

Ram W. Sabnis

Abstract

Novel Compounds as SARS-CoV-2 Main Protease Inhibitors for Treating Viral Infections, in particular, Coronavirus Infections --- Source: OpenAlex - ACS Medicinal Chemistry Letters (Citations: 1) PDF: N/A Original Link: https://doi.org/https://doi.org/10.1021/acsmedchemlett.6c00299

Submitted: June 28, 2026Subjects: Open Science; Virology

Description / Details

Novel Compounds as SARS-CoV-2 Main Protease Inhibitors for Treating Viral Infections, in particular, Coronavirus Infections


Source: OpenAlex - ACS Medicinal Chemistry Letters (Citations: 1) PDF: N/A Original Link: https://doi.org/https://doi.org/10.1021/acsmedchemlett.6c00299

Please sign in to join the discussion.

No comments yet. Be the first to share your thoughts!

Access Paper
Submission Info
Date:
Jun 28, 2026
Topic:
Virology
Area:
Open Science
Comments:
0
Bookmark
Novel Compounds as SARS-CoV-2 Main Protease Inhibitors for Treating Viral Infections, in particular, Coronavirus Infections | Researchia